Avacta Group PLC (AVCT) - Net Assets
Based on the latest financial reports, Avacta Group PLC (AVCT) has net assets worth GBX144.00K GBX (≈ $17.52 USD) as of June 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (GBX29.24 Million ≈ $3.56K USD) and total liabilities (GBX29.09 Million ≈ $3.54K USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check AVCT goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | GBX144.00K |
| % of Total Assets | 0.49% |
| Annual Growth Rate | N/A |
| 5-Year Change | -85.01% |
| 10-Year Change | -51.49% |
| Growth Volatility | 4068.73 |
Avacta Group PLC - Net Assets Trend (2001–2024)
This chart illustrates how Avacta Group PLC's net assets have evolved over time, based on quarterly financial data. See how many days can Avacta Group PLC fund operations to measure how many days the company can operate on defensive assets alone.
Annual Net Assets for Avacta Group PLC (2001–2024)
The table below shows the annual net assets of Avacta Group PLC from 2001 to 2024. For live valuation and market cap data, see AVCT market cap.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | GBX9.28 Million ≈ $1.13K |
-57.44% |
| 2023-12-31 | GBX21.80 Million ≈ $2.65K |
+18.26% |
| 2022-12-31 | GBX18.44 Million ≈ $2.24K |
-55.27% |
| 2021-12-31 | GBX41.22 Million ≈ $5.02K |
-33.44% |
| 2020-12-31 | GBX61.93 Million ≈ $7.53K |
+139.95% |
| 2019-12-31 | GBX25.81 Million ≈ $3.14K |
+20.53% |
| 2018-07-31 | GBX21.41 Million ≈ $2.61K |
-28.36% |
| 2017-07-31 | GBX29.89 Million ≈ $3.64K |
-16.64% |
| 2016-07-31 | GBX35.86 Million ≈ $4.36K |
+87.41% |
| 2015-07-31 | GBX19.13 Million ≈ $2.33K |
-33.65% |
| 2014-07-31 | GBX28.84 Million ≈ $3.51K |
+85.42% |
| 2013-07-31 | GBX15.55 Million ≈ $1.89K |
-8.28% |
| 2012-07-31 | GBX16.96 Million ≈ $2.06K |
+48.27% |
| 2011-07-31 | GBX11.44 Million ≈ $1.39K |
+14.70% |
| 2010-07-31 | GBX9.97 Million ≈ $1.21K |
+20.16% |
| 2009-07-31 | GBX8.30 Million ≈ $1.01K |
+70.40% |
| 2008-07-31 | GBX4.87 Million ≈ $592.42 |
+85.20% |
| 2007-07-31 | GBX2.63 Million ≈ $319.87 |
+18678.57% |
| 2006-04-30 | GBX14.00K ≈ $1.70 |
-33.33% |
| 2005-04-30 | GBX21.00K ≈ $2.56 |
-97.97% |
| 2004-04-30 | GBX1.03 Million ≈ $125.81 |
+549.57% |
| 2003-04-30 | GBX-230.00K ≈ $-27.98 |
+56.52% |
| 2002-04-30 | GBX-529.00K ≈ $-64.36 |
-45.73% |
| 2001-04-30 | GBX-363.00K ≈ $-44.17 |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Avacta Group PLC's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 13837600000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | GBX36.94 Million | 398.03% |
| Other Comprehensive Income | GBX-2.04 Million | -22.01% |
| Other Components | GBX113.21 Million | 1219.83% |
| Total Equity | GBX9.28 Million | 100.00% |
Avacta Group PLC Competitors by Market Cap
The table below lists competitors of Avacta Group PLC ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
GLOW LIFETECH CORP.
F:9DO
|
$3.92 Million |
|
Advance Information Marketing Bhd
KLSE:0122
|
$3.92 Million |
|
SPOBAG AG
F:SBE
|
$3.92 Million |
|
AGS Transact Technologies Limited
NSE:AGSTRA
|
$3.92 Million |
|
ARC Funds Ltd
AU:ARC
|
$3.91 Million |
|
Octopus Titan VCT
LSE:OTV2
|
$3.91 Million |
|
New Concept Energy Inc
NYSE MKT:GBR
|
$3.91 Million |
|
The House of Agriculture Spiroy S.A.
AT:SPIR
|
$3.91 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Avacta Group PLC's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 21,805,000 to 9,281,000, a change of -12,524,000 (-57.4%).
- Net loss of 52,841,000 reduced equity.
- New share issuances of 31,876,000 increased equity.
- Other comprehensive income decreased equity by 364,999.
- Other factors increased equity by 8,805,999.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | GBX-52.84 Million | -569.35% |
| Share Issuances | GBX31.88 Million | +343.45% |
| Other Comprehensive Income | GBX-365.00K | -3.93% |
| Other Changes | GBX8.81 Million | +94.88% |
| Total Change | GBX- | -57.44% |
Book Value vs Market Value Analysis
This analysis compares Avacta Group PLC's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 2588.86x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2001-04-30 | GBX-0.05 | GBX73.50 | x |
| 2002-04-30 | GBX-0.08 | GBX73.50 | x |
| 2003-04-30 | GBX-0.03 | GBX73.50 | x |
| 2004-04-30 | GBX0.15 | GBX73.50 | x |
| 2005-04-30 | GBX0.00 | GBX73.50 | x |
| 2006-04-30 | GBX0.00 | GBX73.50 | x |
| 2007-07-31 | GBX0.38 | GBX73.50 | x |
| 2008-07-31 | GBX0.61 | GBX73.50 | x |
| 2009-07-31 | GBX0.87 | GBX73.50 | x |
| 2010-07-31 | GBX0.79 | GBX73.50 | x |
| 2011-07-31 | GBX0.74 | GBX73.50 | x |
| 2012-07-31 | GBX0.68 | GBX73.50 | x |
| 2013-07-31 | GBX0.49 | GBX73.50 | x |
| 2014-07-31 | GBX0.69 | GBX73.50 | x |
| 2015-07-31 | GBX0.38 | GBX73.50 | x |
| 2016-07-31 | GBX0.53 | GBX73.50 | x |
| 2017-07-31 | GBX0.44 | GBX73.50 | x |
| 2018-07-31 | GBX0.33 | GBX73.50 | x |
| 2020-12-31 | GBX0.27 | GBX73.50 | x |
| 2021-12-31 | GBX0.17 | GBX73.50 | x |
| 2022-12-31 | GBX0.07 | GBX73.50 | x |
| 2023-12-31 | GBX0.08 | GBX73.50 | x |
| 2024-12-31 | GBX0.03 | GBX73.50 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Avacta Group PLC utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -569.35%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -46761.95%
- • Asset Turnover: 0.00x
- • Equity Multiplier: 5.20x
- Recent ROE (-569.35%) is below the historical average (-317.69%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2001 | 0.00% | -1666.67% | 0.04x | 0.00x | GBX-113.70K |
| 2002 | 0.00% | -1509.09% | 0.06x | 0.00x | GBX-113.10K |
| 2003 | 0.00% | 0.00% | 0.00x | 0.00x | GBX-88.00K |
| 2004 | -28.82% | -1568.42% | 0.01x | 1.34x | GBX-401.40K |
| 2005 | -5252.38% | -352.40% | 1.46x | 10.24x | GBX-1.11 Million |
| 2006 | -764.29% | -2675.00% | 0.12x | 2.36x | GBX-108.40K |
| 2007 | -46.37% | -575.00% | 0.07x | 1.08x | GBX-1.48 Million |
| 2008 | -30.16% | -315.11% | 0.09x | 1.06x | GBX-1.96 Million |
| 2009 | -32.36% | -284.43% | 0.10x | 1.09x | GBX-3.51 Million |
| 2010 | -18.85% | -90.90% | 0.18x | 1.13x | GBX-2.88 Million |
| 2011 | -5.17% | -24.17% | 0.20x | 1.08x | GBX-1.73 Million |
| 2012 | -6.52% | -35.34% | 0.17x | 1.09x | GBX-2.80 Million |
| 2013 | -9.78% | -56.33% | 0.15x | 1.14x | GBX-3.08 Million |
| 2014 | -5.17% | -46.92% | 0.10x | 1.08x | GBX-4.38 Million |
| 2015 | -52.99% | -559.24% | 0.08x | 1.12x | GBX-12.05 Million |
| 2016 | -12.96% | -214.64% | 0.06x | 1.05x | GBX-8.23 Million |
| 2017 | -21.30% | -232.80% | 0.09x | 1.06x | GBX-9.36 Million |
| 2018 | -41.23% | -319.54% | 0.12x | 1.10x | GBX-10.97 Million |
| 2020 | -30.50% | -881.11% | 0.03x | 1.09x | GBX-25.08 Million |
| 2021 | -63.84% | -894.80% | 0.06x | 1.14x | GBX-30.44 Million |
| 2022 | -200.35% | -382.68% | 0.10x | 5.02x | GBX-38.78 Million |
| 2023 | -114.41% | -875.03% | 0.04x | 3.36x | GBX-27.13 Million |
| 2024 | -569.35% | -46761.95% | 0.00x | 5.20x | GBX-53.77 Million |
Industry Comparison
This section compares Avacta Group PLC's net assets metrics with peer companies in the Biotechnology industry.
Industry Context
- Industry: Biotechnology
- Average net assets among peers: $3,842,919
- Average return on equity (ROE) among peers: -73.81%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Avacta Group PLC (AVCT) | GBX144.00K | 0.00% | 202.03x | $3.91 Million |
| 4BASEBIO UK SOCIETAS (4BB) | $-492.00K | 0.00% | 0.00x | $989.13K |
| Aptamer Group PLC (APTA) | $8.05 Million | -26.00% | 0.43x | $155.87K |
| Arecor Therapeutics PLC (AREC) | $6.45 Million | 10.29% | 0.26x | $287.12K |
| BSF Enterprise Plc (BSFA) | $4.86 Million | -30.89% | 0.08x | $15.23K |
| Bioventix (BVXP) | $6.58 Million | 38.84% | 0.05x | $1.16 Million |
| Cizzle Biotechnology Holdings PLC (CIZ) | $937.00K | -418.46% | 0.23x | $137.45K |
| Amur Minerals Corporation (CRTX) | $22.23 Million | -6.94% | 0.04x | $64.52K |
| Fusion Antibodies PLC (FAB) | $1.12 Million | -231.17% | 0.84x | $165.94K |
| Faron Pharmaceuticals Oy (FARN) | $-15.16 Million | 0.00% | 0.00x | $602.85K |
About Avacta Group PLC
Avacta Group Plc, together with its subsidiaries, engages in the development of cancer therapies in the United Kingdom, South Korea, and internationally. Its lead product candidate is AVA6000, a peptide drug conjugate form of doxorubicin, which is an approved cancer drug with known severe toxicities. The company is developing AVA6103, a peptide drug conjugate technology designed to deliver exatec… Read more